-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lenvatinib Mesylate in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lenvatinib Mesylate in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data....
-
Thematic Analysis
NewEnterprise Security Software Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Artificial intelligence (AI) is a double-edged sword in cybersecurity. It can help organizations improve their threat detection, hunting, and incident response capabilities, but adversaries can and will use AI in cyberattacks. There is every likelihood that AI will spur new merger and acquisition (M&A) deals in cybersecurity, especially of companies judged to be AI specialists. In the thematic screen of GlobalData’s enterprise security software sector scorecard, AI has a weighting of 20%, higher than any other theme.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Teserpaturev in Malignant Pleural Mesothelioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Teserpaturev in Malignant Pleural Mesothelioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Teserpaturev in Malignant Pleural Mesothelioma Drug Details: Teserpaturev (Delytact) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ficerafusp Alfa in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ficerafusp Alfa in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ficerafusp Alfa in Colorectal Cancer Drug Details: Ficerafusp alfa (BCA-101)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ficerafusp Alfa in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ficerafusp Alfa in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ficerafusp Alfa in Pancreatic Cancer Drug Details: Ficerafusp alfa (BCA-101)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ficerafusp Alfa in Recurrent Head And Neck Squamous Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ficerafusp Alfa in Recurrent Head And Neck Squamous Cell Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ficerafusp Alfa in Recurrent Head...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ficerafusp Alfa in Cutaneous Squamous Cell Carcinoma (cSCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ficerafusp Alfa in Cutaneous Squamous Cell Carcinoma (cSCC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ficerafusp Alfa in Cutaneous Squamous Cell Carcinoma...
-
Sector Analysis
NewIran Cards and Payments – Opportunities and Risks to 2028
Iran Cards and Payments Market Report Overview The annual value of card transactions in the Iran cards and payments market was $3.9 trillion in 2023. The value will grow at a CAGR of more than 18% during 2024-2028 owing to the improvements to the country’s payments infrastructure and an increase in the number of retailers accepting payment cards. Iran Card Transactions Outlook, 2023-2028 ($ Trillion) Buy the Full Report for More Information on the Iran Cards and Payments Market Forecast...
-
Sector Analysis
NewMorocco Cards and Payments – Opportunities and Risks to 2028
Morocco Cards and Payments Market Report Overview The annual value of card transactions in the Morocco cards and payments market was $6.3 billion in 2023 and will grow at a CAGR of more than 12% during 2024-2028. Cash remains a strong preference for Moroccan consumers. However, the government and banks are striving to increase awareness levels to encourage electronic payments. Morocco Card Transactions Outlook, 2023-2028 ($ Billion) Buy the Full Report for More Information on the Morocco Cards and Payments...
-
Thematic Analysis
NewCloud Gaming – Thematic Intelligence
Cloud Gaming Thematic Report Overview Cloud gaming allows video games to be streamed directly from the cloud and played using any device with a display and an internet connection. Its ease of use and flexibility will transform how games are distributed, consumed, and monetized. Cloud gaming’s success depends on the availability of reliable, fast networks, large game libraries, and competitive pricing. Some companies will use ad or usage-based plans to attract casual users. However, data privacy and copyright issues must...